Just wanted to chime in...... to once again say YOU'RE WELCOME to all of those prudent investors who came along with me when I dropped THCX for BELEAVE. We've even done more volume than you guys on the CSE haha
But seriously it's a no brainer. ~30,000 production capacity by later this year, have a sales licence, own a network of clinics to distribute some products for beautiful margins. Market cap is less than $100M and should be sitting between $300M-$600M. Rumblings of a 200k sq ft facility in the works as well.
I'll be back to THCX, but comparing ratios of prod. capacity to market cap, BELEAVE beats THCX by a long shot.